Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-21-008779
Filing Date
2021-03-17
Accepted
2021-03-16 19:58:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G nc10020664x2_sc13g.htm SC 13G 48662
  Complete submission text file 0001140361-21-008779.txt   50159
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Subject) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79996 | Film No.: 21747928
SIC: 2834 Pharmaceutical Preparations

Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address
Sooch Mina (Filed by) CIK: 0001674006 (see all company filings)

Type: SC 13G